Logo image of ALX.AS

ALUMEXX N.V. (ALX.AS) Stock Fundamental Analysis

AMS:ALX - Euronext Amsterdam - NL0012194724 - Common Stock - Currency: EUR

1.38  +0.01 (+0.73%)

Fundamental Rating

2

Overall ALX gets a fundamental rating of 2 out of 10. We evaluated ALX against 19 industry peers in the Building Products industry. ALX has a bad profitability rating. Also its financial health evaluation is rather negative. ALX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALX has reported negative net income.
ALX had a positive operating cash flow in the past year.
ALX had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALX reported negative operating cash flow in multiple years.
ALX.AS Yearly Net Income VS EBIT VS OCF VS FCFALX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500K -500K 1M 1.5M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.22%, ALX is doing worse than 68.42% of the companies in the same industry.
ALX has a Return On Equity of -18.83%. This is in the lower half of the industry: ALX underperforms 78.95% of its industry peers.
With a Return On Invested Capital value of 2.86%, ALX is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for ALX is above the industry average of 6.39%.
The 3 year average ROIC (11.11%) for ALX is well above the current ROIC(2.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.22%
ROE -18.83%
ROIC 2.86%
ROA(3y)5.99%
ROA(5y)6.16%
ROE(3y)10.32%
ROE(5y)11.5%
ROIC(3y)11.11%
ROIC(5y)11.66%
ALX.AS Yearly ROA, ROE, ROICALX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

The Operating Margin of ALX (2.84%) is worse than 73.68% of its industry peers.
In the last couple of years the Operating Margin of ALX has declined.
ALX has a Gross Margin of 47.69%. This is in the better half of the industry: ALX outperforms 78.95% of its industry peers.
In the last couple of years the Gross Margin of ALX has grown nicely.
Industry RankSector Rank
OM 2.84%
PM (TTM) N/A
GM 47.69%
OM growth 3Y-4.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.33%
GM growth 5Y15.87%
ALX.AS Yearly Profit, Operating, Gross MarginsALX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

ALX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALX has been increased compared to 1 year ago.
Compared to 5 years ago, ALX has more shares outstanding
ALX has a worse debt/assets ratio than last year.
ALX.AS Yearly Shares OutstandingALX.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ALX.AS Yearly Total Debt VS Total AssetsALX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

ALX has an Altman-Z score of 0.90. This is a bad value and indicates that ALX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, ALX is doing worse than 84.21% of the companies in the same industry.
ALX has a debt to FCF ratio of 5.90. This is a neutral value as ALX would need 5.90 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.90, ALX is in line with its industry, outperforming 47.37% of the companies in the same industry.
A Debt/Equity ratio of 4.77 is on the high side and indicates that ALX has dependencies on debt financing.
With a Debt to Equity ratio value of 4.77, ALX is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF 5.9
Altman-Z 0.9
ROIC/WACC0.38
WACC7.57%
ALX.AS Yearly LT Debt VS Equity VS FCFALX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.81 indicates that ALX should not have too much problems paying its short term obligations.
The Current ratio of ALX (1.81) is better than 68.42% of its industry peers.
A Quick Ratio of 0.56 indicates that ALX may have some problems paying its short term obligations.
The Quick ratio of ALX (0.56) is worse than 84.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.56
ALX.AS Yearly Current Assets VS Current LiabilitesALX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALX have decreased strongly by -270.45% in the last year.
Looking at the last year, ALX shows a very strong growth in Revenue. The Revenue has grown by 105.19%.
Measured over the past years, ALX shows a very strong growth in Revenue. The Revenue has been growing by 85.44% on average per year.
EPS 1Y (TTM)-270.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%261.87%
Revenue 1Y (TTM)105.19%
Revenue growth 3Y102.7%
Revenue growth 5Y85.44%
Sales Q2Q%37.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALX.AS Yearly Revenue VS EstimatesALX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALX.AS Price Earnings VS Forward Price EarningsALX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALX's Enterprise Value to EBITDA ratio is in line with the industry average.
100.00% of the companies in the same industry are more expensive than ALX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.2
EV/EBITDA 6.9
ALX.AS Per share dataALX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALUMEXX N.V.

AMS:ALX (4/28/2025, 7:00:00 PM)

1.38

+0.01 (+0.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.39%
Ins Owner ChangeN/A
Market Cap9.66M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF 2.2
P/OCF 1.86
P/B 2.12
P/tB N/A
EV/EBITDA 6.9
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY45.45%
OCF(TTM)0.74
OCFY53.84%
SpS5.74
BVpS0.65
TBVpS-1.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -18.83%
ROCE 3.81%
ROIC 2.86%
ROICexc 3%
ROICexgc 6.47%
OM 2.84%
PM (TTM) N/A
GM 47.69%
FCFM 10.94%
ROA(3y)5.99%
ROA(5y)6.16%
ROE(3y)10.32%
ROE(5y)11.5%
ROIC(3y)11.11%
ROIC(5y)11.66%
ROICexc(3y)14.91%
ROICexc(5y)27.71%
ROICexgc(3y)26.54%
ROICexgc(5y)N/A
ROCE(3y)14.88%
ROCE(5y)15.59%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-62.74%
ROICexc growth 5YN/A
OM growth 3Y-4.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.33%
GM growth 5Y15.87%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF 5.9
Debt/EBITDA 4.4
Cap/Depr 21.27%
Cap/Sales 2.02%
Interest Coverage 0.78
Cash Conversion 105.03%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.56
Altman-Z 0.9
F-Score6
WACC7.57%
ROIC/WACC0.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-270.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%261.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)105.19%
Revenue growth 3Y102.7%
Revenue growth 5Y85.44%
Sales Q2Q%37.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y256.25%
EBIT growth 3Y94.22%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y928.3%
FCF growth 3Y-27.63%
FCF growth 5Y-2.56%
OCF growth 1Y1081.32%
OCF growth 3Y16.38%
OCF growth 5Y29.58%